Hemp Extracts

New tox study validates safe upper dose for cbdMD’s Broad Spectrum CBD blend

25-Sep-2023 By Stephen Daniells

cbdMD's proprietary broad spectrum blend is safe when consumed as a dietary supplement in doses up to 160 mg per day in a 70 kg (154 lb), says a new study published in Regulatory Toxicology and Pharmacology.

Charlotte’s Web-Canopy Growth analysis identifies safe CBD intake levels for supplements

18-Sep-2023 By Claudia Adrien

Upper CBD intake levels ranging from 70 mg to 160 mg per day for dietary supplements are acceptable and do not harm the liver, says a new scientific review commissioned by Canopy Growth Corporation and Charlotte’s Web.

‘The risk we have here is enough to manage’: Athlete turned entrepreneur Floyd Landis discusses how regulatory uncertainty threatens the global CBD industry

15-Sep-2023 By Oliver Morrison

Regulatory bottlenecks are threatening to hinder CBD innovation on both sides of the Atlantic, the former professional road racing cyclist Floyd Landis tells FoodNavigator.

Top CBD companies’ lackluster sales, profits point to years-long national trend

08-Sep-2023 By Claudia Adrien

The US cannabidiol industry has seen a year-over-year decline in sales, despite attempts to bolster the CBD market with newer products.

cbdMD CSO: ‘It appears that we’re finally making headway in Congress’

22-Aug-2023 By Stephen Daniells

The recent congressional hearing about CBD and subsequent ‘historic’ bicameral Request for Information (RFI) shows that hemp-derived CBD for use in dietary supplements has finally got the attention of Congress, said cbdMD’s CSO.

Guest Article

Ex-Health Canada NHP DG: ‘Cannabis is Canada’s New Wild West’

06-Jun-2023 By Adam Gibson, President, True Moderation

When it comes to regulating CBD and cannabis, Canada is an extreme cautionary tale for the US, says Adam Gibson, the former Director General of Health Canada’s Non-prescription and Natural Health Products Directorate.

NutraWomen Wednesday: Inesa Ponomariovaite, Founder, Nesa's Hemp

08-Feb-2023 By Danielle Masterson

She may be a serial entrepreneur, humanitarian, health coach and the founder of a hemp company, but perhaps what makes Inesa Ponomariovaite stand out the most is her incredible story of survival.

NPA's Fabricant on CBD, State-led regulations, and NMN's dangerous precedent

31-Jan-2023 By Stephen Daniells

2023 may be a New Year, but many of the old issues for the dietary supplements industry remain. In this wide-ranging interview with Daniel Fabricant, PhD, CEO of the Natural Products Association, we dug into some of the most front-of-mind issues for this...

CBD in 2022: A year in review

06-Dec-2022 By Danielle Masterson

We’re five years in, so what does the CBD industry look like now and what can we expect in 2023? We spoke with several CBD experts who walked us through the highs and lows of 2022.

‘A continuing pattern of antagonism by FDA toward CBD in food and beverages’: Experts weigh in on recent warning letters

05-Dec-2022 By Stephen Daniells

The recent raft of warning letters to brands selling CBD-infused foods and beverages marked a shift in FDA approaches to the ingredient, with the Agency seeming to opine that food and beverages are “somehow a greater risk than supplements”.

'Quite frankly, I'm concerned for our entire industry...' FDA cracks down on firms selling CBD-infused foods & beverages in ‘aggressive’ new stance

22-Nov-2022 By Elaine Watson

The FDA has sent out a raft of warning letters to brands selling CBD-infused foods and beverages, adopting an “aggressive position” that one industry source told us made him “concerned for our entire industry.”

NutraCast: How amendments in the 2023 Farm Bill could shape the hemp industry

13-Oct-2022 By Danielle Masterson

Over the course of the next year, lawmakers on the US House and Senate agriculture committees will draft a new federal Farm Bill that will shape a number of programs for the next five years. What does that mean for the hemp industry?

CBD entrepreneur Floyd Landis to share vision in upcoming NutraIngredients-USA webinar

10-Oct-2022 By Hank Schultz

Some CBD entrepreneurs talk a good game when it comes to their companies’ mission statements. Former pro cyclist Floyd Landis has lived his.

Upcoming webinar to examine tumultuous CBD market

28-Sep-2022 By Hank Schultz

Demand for CBD ingredients remains high and innovation continues apace even as the regulatory uncertainty of the category persists. A panel of influential speakers will delve into these and other questions in an upcoming webinar hosted by NutraIngredients-USA.

SPECIAL REPORT: Hemp-derived CBD… ‘We're operating in a constrained addressable market with a patchwork of state-based regulations’

02-Sep-2022 By Elaine Watson

“I see all these emails going around saying once the [2018] Farm Bill passes, CBD is legal in all 50 states… and that’s just not true,” observed one attorney in December 2018. Four years later, while a lot has changed, the FDA maintains that CBD is not...

CBD brand Trip expands its foothold in US, launches gummies with $12m fundraise

26-Aug-2022 By Elizabeth Crawford

After dominating the UK CBD space with help from a highly engaged online fanbase, CBD beverage, oil and gummy brand Trip is hoping to cement a similar position in the US – but this time with the additional aid of $12m in funding from prominent entrepreneurs...

AHPA’s updated Hemp Lexicon seeks to shed light on ‘full spectrum’ question

25-Aug-2022 By Hank Schultz

The American Herbal Products Association has released a new guidance document that seeks to bring clarity to hemp nomenclature, in particular what ought to be meant by the terms ‘broad spectrum’ and ‘full spectrum’ extracts.

Charlotte’s Web to hop on CBD sports bandwagon with new NSF-certified product line

15-Aug-2022 By Hank Schultz

CBD manufacturer Charlotte’s Web has announced the planned launch of a line of CBD products aimed at the sports market that will feature an NSF Certified for Sport mark.

Provisions of Senate bill could decimate hemp industry, industry group asserts

10-Aug-2022 By Hank Schultz

Legislation currently in the Senate could burden the hemp industry by setting an unrealistically low level of allowable THC, an industry group has said.

Majority of CBD products tested in study found to have at least some THC

29-Jun-2022 By Hank Schultz

A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.

Kemin enters hemp-CBD space with Luxiva distillates range

15-Jun-2022 By Stephen Daniells

Iowa-based Kemin is expanding its portfolio to introduce a range of USDA-certified organic, traceable, U.S.-grown hemp CBD distillates for use in health and wellness products.

HempRise introduces 5% CBD nanoemulsion

09-Jun-2022 By Danielle Masterson

The vertically-integrated supplier of hemp extracts and cannabinoid ingredients recently introduced HempNANO, its new concentrated nanoemulsion for water soluble applications.

Study: Many CBD products would trigger doping bans

09-Jun-2022 By Shane Starling

Almost a third of 23 tested CBD products contained traces of banned cannabinoids at levels that would have provoked doping infringements, according to a just-published study.

NutraWomen Wednesday: Paola Fernandez, Founder and CEO of High Hemp

25-May-2022 By Danielle Masterson

While working at her father’s cigar company, Paola Fernandez invented a ‘natural’ alternative to tobacco-based rolling paper. In 2016, High Hemp was born and sells its flagship hemp wraps along with CBD gummies and tinctures. In under 5 years, Fernandez...

FDA slams Delta-8 THC sellers over claims

04-May-2022 By Hank Schultz

FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.

NutraCast: Evo Hemp joins 40-Acre Co-Op to level farming opportunity

22-Apr-2022 By Danielle Masterson

When you picture a farmer, who comes to mind?

FDA, FTC slap seven CBD firms with COVID-19 warning letters

01-Apr-2022 By Hank Schultz

Seven marketers of CBD products received warning letters for making COVID-19 treatment claims as part of the ongoing joint FDA/FTC enforcement action.

Best companies will prevail as CBD market goes through painful winnowing, CEO says

24-Feb-2022 By Hank Schultz

The hemp/CBD market is going through a reckoning but ultimately will emerge in a stronger position, said the head of one of few publicly traded companies in the sector.

NPA submits citizen’s petition demanding resolution on CBD issue

22-Feb-2022 By Hank Schultz

The Natural Products Association has filed a citizen’s petition calling for FDA to either rule that CBD is a legal dietary ingredient or to make a rule allowing enforcement discretion on the substance.

Canadian firm Relevium struggles with direction as restriction placed on stock trades

23-Dec-2021 By Hank Schultz

Canadian firm Relevium Technologies says it will file its belated financial statements by the end of January 2022, which would lift a ban placed by regulators on sales of stock by the company’s management.

Industry sounds alarm over Oregon’s proposed restrictions on hemp/CBD products

15-Dec-2021 By Hank Schultz

New rules proposed in Oregon that would see restrictions placed around the sale most full spectrum hemp extracts have sounded alarm bells in the hemp/CBD industry. Stakeholders are scrambling to respond before the rules go into effect, which could be...

USP commentary sounds safety, quality alarm on delta-8 THC

03-Dec-2021 By Hank Schultz

The United States Pharmacopeia (USP) has published a commentary raising potential safety and quality control concerns about the delta-8 THC products flooding the market. The document also raised issues with other cannabinoids that are being isolated...

World's 5th biggest economy now fully open to hemp/CBD products

07-Oct-2021 By Hank Schultz

California Gov. Gavin Newsom has signed a bill into law making hemp/CBD supplements and foods legal after an unsettled period in which the state health department was following a federal lead in ruling that CBD was not a legal dietary ingredient.

California Gov. Newsom expected to sign hemp bill

13-Sep-2021 By Hank Schultz

The California Legislature has passed a bipartisan bill to establish rules for the production and marketing of CBD/hemp products. Proponents expect Gov. Gavin Newsom to sign the bill into law before the Oct. 10 deadline.

CV Sciences’ Q2 revenue rebounds after challenging Q1

13-Aug-2021 By Stephen Daniells

CBD products manufacturer CV Sciences has recorded quarter-on-quarter increases in revenue, with increasing retail distribution and a “strong” innovation pipeline leading to bullish predictions for the rest of 2022.

FDA rejects two NDI filings on full spectrum hemp extracts

11-Aug-2021 By Hank Schultz

The US Food and Drug Administration has rejected two New Dietary Ingredient Notifications for CBD ingredients. Industry stakeholders said the fact of the rejections and some of wording used in the letters makes it clear that new legislation is likely...

Israeli firm claims to have cracked plant tissue production code with polyphenol, cannabinoid ingredients

19-Jul-2021 By Hank Schultz

Israeli technology firm BioHarvest Sciences claims to have cracked the cell tissue production code as it brings the first fruits of its labor to market — a resveratrol-heavy offering made from cells taken from the skin of red grapes. Cannabinoids...

Schumer bill mandates legal pathway for CBD supplements, directs FDA to set safe upper exposure limit

15-Jul-2021 By Hank Schultz

A bill put forward by Senate Majority leader Chuck Schumer, D-NY, to decriminalize marijuana includes language on CBD that has been welcomed by supplement industry stakeholders.

Cannabinoid fermentation specialist eyes Mexican market

12-Jul-2021 By Hank Schultz

The advent of a strategic patent has put formulation specialist Biomedican on course to fundamentally alter the cannabinoid supply picture, the company claims. In addition, a Mexican court ruling has opened up opportunities south of the border.

‘Full spectrum CBD’ means being honest about the THC content, manufacturer says

06-Jul-2021 By Hank Schultz

Not shying away from the THC content is the best way to offer a ‘full spectrum’ CBD product, a Kentucky-based manufacturer advocates.

Hemp advocates say recent FDA communique makes need for legislation even more pressing

01-Jul-2021 By Hank Schultz

The publication of a recent FDA priorities list that omitted the hemp/CBD question is a reminder that a legislative solution is the only practical way forward for a regulatory resolution for these ingredients, advocates say.

cbdMD exec says future bright for brands with enough cash and right ethos

11-Jun-2021 By Hank Schultz

Despite a pessimistic outlook for the state of the CBD market, the CEO of a leading brand said there’s plenty of opportunity for companies committed to doing things the right way.

Bipartisan Senate CBD bill introduced

19-May-2021 By Hank Schultz

A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.

Introduction of Senate hemp market bill expected soon

17-May-2021 By Hank Schultz

A Senate version of a bill legalizing CBD as a dietary ingredient is reportedly slated to be introduced soon, perhaps as early as this week.

CV Sciences’ revenue plummets, reflecting overall contraction of CBD market

14-May-2021 By Hank Schultz

CBD products manufacturer CV Sciences has recorded a sharp decline in revenue, mirroring reports of an overall contraction in the market for hemp extract products.

CV Sciences, Alkemist Labs team up with NIST to improve hemp/CBD testing

14-Apr-2021 By Hank Schultz

Leading hemp/CBD firm CV Sciences is partnering with Alkemist Labs and a government agency to improve the state of the art in cannabinoids testing.

Colorado unveils plan to bolster state support of hemp industry

30-Mar-2021 By Hank Schultz

The state of Colorado aims to remain a leader in the hemp industry, Gov. Jared Polis said at an industry event last week. He announced the release of a detailed state plan for the industry at the meeting, which includes scientific support, data sharing,...

Caution replaces euphoria as hemp event attendees wrestle with changing market

29-Mar-2021 By Hank Schultz

The CBD/hemp markets, both in finished goods and on the supply side, are in a state of transition, attendees at an industry event learned on Friday. The message was that some growers and some finished product marketers are likely to fall by the wayside...

CBD safety: Large-scale study finds no evidence of liver toxicity from oral CBD products

23-Mar-2021 By Stephen Daniells

Colorado-based ValidCare has announced the preliminary findings from its industry-sponsored, decentralized human safety study of hemp derived CBD products, with the data indicating no liver toxicity.

NPA, others support CA CBD bill while still advocating for federal solution

11-Mar-2021 By Hank Schultz

Yesterday the Natural Products Association testified in favor of a California bill to regulate the CBD trade in that state. NPA and others, however, have reiterated a call for federal legislation that would forestall the growing patchwork quilt of state...